CLDX Earnings

Quarterly EPS
$-0.64
Q3 2024
$-0.71
Q4 2024
$-0.81
Q1 2025
$-0.85
Q2 2025
$-1.01
Q3 2025
$-1.22
Q4 2025
$-1.18
Q1 2026
$-0.94
Q2 2026
Latest Revenue22.0K
Latest Net Income-73503000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.9422.0K-73503000-97.0%-10.6%
Q1 2026-$1.1815.0K-78685000-97.8%-45.7%
Q4 2025-$1.22121.0K-81317000-89.7%-71.8%
Q3 2025-$1.010-67044000-100.0%-57.8%
Q2 2025-$0.85730.0K-56600000-70.8%-57.4%
Q1 2025-$0.81695.0K-53796000+345.5%-44.6%
Q4 2024-$0.711.2M-47092000-71.6%+14.5%
Q3 2024-$0.643.2M-42121000+110.3%+21.0%
Q2 2024-$0.542.5M-35842000
Q1 2024-$0.56156.0K-32808000
Q4 2023-$0.834.1M-43306000
Q3 2023-$0.811.5M-38260000
Celldex Therapeutics (CLDX) — Earnings